TP53 is the most frequently mutated gene in more aggressive breast cancer subtypes, the estrogen receptor (ER) negative Her2+ and triple negative (TNBC) breast cancers, where TP53 mutations occur in more than 50% of cases [3,4,5,6]. Here, ESR1 is linked to breast carcinoma.